Free Account Opening + AMC Free Demat
Loading...

Alkem Laboratories IPO vs Quick Heal IPO

Comparision between Alkem Laboratories IPO and Quick Heal IPO.

IPO Details

Alkem Laboratories IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Quick Heal IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Alkem Laboratories IPO is up to ₹1,349.61 Cr whereas the issue size of the Quick Heal IPO is up to ₹451.25 Cr. The final issue price of Alkem Laboratories IPO is ₹1,050.00 per share and of Quick Heal IPO is ₹321.00 per share.

  Alkem Laboratories IPO Quick Heal IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹1,020.00 per share ₹311.00 per share
Issue Price (Upper) ₹1,050.00 per share ₹321.00 per share
Issue Price (Final) ₹1,050.00 per share ₹321.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 14 shares 45 shares
Fresh Issue Size 77,88,161 shares
Fresh Issue Size (Amount) up to ₹250.00 Cr
OFS Issue Size 62,69,558 shares
OFS Issue Size (Amount) up to ₹201.25 Cr
Issue Size Total 1,28,53,442 shares 1,40,57,719 shares
Issue Size Total (Amount) up to ₹1,349.61 Cr up to ₹451.25 Cr

IPO Timetable

Alkem Laboratories IPO opens on Dec 08, 2015, while Quick Heal IPO opens on Feb 08, 2016. The closing date of Alkem Laboratories IPO and Quick Heal IPO is Dec 10, 2015, and Feb 10, 2016, respectively.

  Alkem Laboratories IPO Quick Heal IPO
Anchor Bid Date
Issue Open Dec 08, 2015 Feb 08, 2016
Issue Close Dec 10, 2015 Feb 10, 2016
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Alkem Laboratories IPO P/E ratio is , as compared to Quick Heal IPO P/E ratio of .

  Alkem Laboratories IPO Quick Heal IPO
Financial
ParticularsFor the year/period ended (in Rs. Million)
31 Mar 1531 Mar 1431 Mar 1331 Mar 12
Total Income33,595.2028,395.8024,690.1020,640.10
Profit After Tax (PAT)4,370.904,402.004,667.804,318.10

Particulars

For the year/period ended (in Rs. Million)
31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12 31-Mar-11
Total Liabilities 4,336.79 3,830.14 3,144.98 2,295.86 1,607.93
Total Assets 4,336.79 3,830.14 3,144.98 2,295.86 1,607.93
Total Revenue 2,922.50 2,537.49 2,146.34 1,846.57 1,331.12
Profit After Tax (PAT) 562.98 615.53 775.38 681.95 385.77
Promoter Shareholding (Pre-Issue) 70.87%
Promoter Shareholding (Post-Issue) 66.23%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 15.4%%

Shares Offered

In the Alkem Laboratories IPO retail investors (RII) are offered 43,94,086 shares while in Quick Heal IPO retail investors are offered 43,94,086 shares. Qualified institutional buyers (QIB) are offered 25,10,906 shares in Alkem Laboratories IPO and 29,03,099 shares in Quick Heal IPO.

  Alkem Laboratories IPO Quick Heal IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 25,10,906 shares 29,03,099 shares
NII 18,83,179 shares 21,22,106 shares
RII 43,94,086 shares 49,51,581 shares
Employee 2,98,913 shares 1,60,771 shares
Others
Total 90,87,084 shares 1,01,37,557 shares

Bids Received (Subscription)

Alkem Laboratories IPO subscribed 44.29x in total, whereas Quick Heal IPO subscribed 10.80x.

  Alkem Laboratories IPO Quick Heal IPO
QIB (times) 57.19x 4.34x
NII (times) 129.96x 36.69x
Big NII (times)
Small NII (times)
RII (times) 3.17x 3.82x
Employee (times) 0.67x 0.23x
Other (times)
Total (times) 44.29x 10.80x

Comments

Add a public comment...